ABVC BioPharma, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ABVC, updated each market day.
ABVC AI Sentiment
AI predicts ABVC BioPharma, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About ABVC BioPharma, Inc. Common Stock
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Sector
Exchange
Market Cap
$36,661,231
Cap Tier
Employees
19
Headquarters
FREMONT, CA
Listed Since
Nov. 9, 2004
Website
ABVC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ABVC Volatility
ABVC BioPharma, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
